Bcl-2 overexpression in hepatic stellate cell line CFSC-2G, induces a pro-fibrotic state

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 7, 2010, Pages 1306-1314

  González Puertos, Viridiana Y ^a   Hernández Pérez, Elizabeth ^a   Nuño Lámbarri, Natalia ^a   Ventura Gallegos, José L ^c   López Diázguerrero, Norma E ^a   Robles Díaz, Guillermo ^b   Gutiérrez Ruiz, María C ^a   Konigsberg, Mina ^a  

^a Metropolitan Independent University   (Mexico)

^b Experimental Medicine Unit   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

acetaldehyde; Bcl 2; extracellular matrix; liver fibrosis; oxidative stress

Indexed keywords

ACETALDEHYDE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGENASE 3; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; MESSENGER RNA; PROTEIN BCL 2; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; ACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; MMP13 PROTEIN, RAT; OXIDIZING AGENT; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SMOOTH MUSCLE ACTIN, RAT; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL LINE; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DNA SYNTHESIS; EXTRACELLULAR MATRIX; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; STELLATE CELL; WESTERN BLOTTING; ANIMAL; DNA REPLICATION; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HUMAN; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; TIME; UPREGULATION; DISEASE COURSE; LIVER FIBROSIS; OXIDATION;

ACETALDEHYDE; ACTINS; ANIMALS; CELL AGING; CELL LINE; CELL PROLIFERATION; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR MATRIX; GTP-BINDING PROTEINS; HEPATIC STELLATE CELLS; HUMANS; HYDROGEN PEROXIDE; LIVER CIRRHOSIS; MATRIX METALLOPROTEINASE 13; OXIDANTS; OXIDATIVE STRESS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSGLUTAMINASES; UP-REGULATION;

EID: 77954007916     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06175.x     Document Type: Article

References (43)

1. Friedman SL. Liver fibrosis: from bench to bedside. J. Hepatol. 2003 38 : 38 53.
2. Gutiérrez-Ruiz MC, Gómez-Quiroz LE. Liver fibrosis: searching for cell model answers. Liver Int. 2007 27 : 434 439.
3. Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm. Res. 2008 25 : 249 258.
4. Parona M, Pinzani M. Hepatic wound repair. Fibrogen. Tissue Rep. 2009 2 : 4.
5. Theret N, Musso O, L'Helgoualch A, Champion JP, Clement B. Differential expression and origin of membrane-type 1 and 2 matrix metalloproteinases (MTMMPs) in association with MMP2 activation in injured human livers. Am. J. Pathol. 1998 153 : 945 954.
6. Iredale JP, Benyon RC, Arthur MJ et al. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 1996 24 : 176 184.
7. Liber CS, Weiss DG, Paronetto F et al. Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease. Alcohol. Clin. Exp. Res. 2008 32 : 1031 1039.
8. Chen CS, Wu CH, Lai YC et al. NF-kB-activated tissue transglutaminase is involved in ethanol-induced hepatic injury and the possible role of propolis in preventing fibrogenesis. Toxycology 2008 246 : 148 157.
9. Parola M, Robino G. Oxidative stress-related molecules and liver fibrosis. J. Hepatol. 2001 35 : 297 306.
10. Urtasun R, de la Rosa LC, Nieto N. Oxidative and nitrosative stress and fibrogenic response. Clin. Liver Dis. 2008 12 : 769 790.
11. Svegliati-Baroni G, d'Ambrosio L, Ferretti G et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 1998 27 : 720 726.
12. Galli A, Svegliati-Baroni G, Ceni E et al. Invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005 41 : 1074 1084.
13. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol. Aspects. Med. 2008 29 : 9 16.
14. Gressner AN, Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players of therapeutics targets. J. Cell Mol. Med. 2006 10 : 76 99.
15. Novo E, Marra F, Zamara E et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 2006 55 : 1174 1182.
16. Schinzel A, Kaufmann T, Borner C. Bcl-2 family members: integrators of survival and death signals in physiology and pathology. Biochim. Biophys. Acta 2004 1644 : 95 105.
17. Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007 26 : 1324 1337.
18. Youle RJ, Strasser A. The Bcl-2 protein family: opposing activities that mediate cell death. Nat. Rev. 2008 9 : 47 59.
19. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993 75 : 241 251.
20. Kowaltowski AJ, Fenton RG, Fiskum G. Bcl-2 family proteins regulate mitochondrial reactive oxygen production and protect against oxidative stress. Free Radic. Biol. Med. 2004 37 : 1845 1853.
21. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress Bcl-2 is involved. Cancer Res. 1995 55 : 2284 2292.
22. Tombor B, Rundell K, Oltvai ZN. Bcl-2 promotes premature senescence induced by oncogenic Ras. Biochem. Biophys. Res. Com. 2003 303 : 800 807.
23. López-Diazguerrero NE, López-Araiza H, Conde- Pérezprina JC et al. Bcl-2 protects against oxidative stress while inducing premature senescence. Free. Radic. Biol. Med. 2006 40 : 1161 1169.
24. Borner C. Diminished cell proliferation associated with the death-protective activity of Bcl-2. J. Biol. Chem. 1996 271 : 12695 12698.
25. Vairo G, Innes KM, Adams JM. Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. Oncogene. 1996 13 : 1511 1519.
26. Cárdenas-Aguayo MC, Santa-Olalla J, Baizabal JM, Salgado LM, Covarrubias L. Growth factor deprivation induces an alternative non-apoptotic death mechanism that is inhibited by Bcl-2 in cells derived from neural precursor cells. J. Hemato. Stem Cell Res. 2003 12 : 735 748.
27. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976 248 254.
28. Dimri GP, Lee X, Basile G et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995 92 : 9363 9367.
29. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993 15 : 532 537.
30. Quiroz SC, Bucio L, Souza V et al. Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. J. Gastroenterol. Hepatol. 2001 16 : 1267 1273.
31. Tsujimoto Y, Ikegaki N, Croce CM. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987 2 : 3 7. (Pubitemid 18021064)
32. Jang JH, Surh YJ. Potentiation of cellular antioxidant capacity by Bcl-2: implications for its antiapoptotic function. Biochem. Pharmacol. 2003 66 : 1371 1379.
33. Vairo G, Soos T, Upton TM et al. Bcl-2 retards cell cycle entry through p27Kip1, pRb relative p130, and altered E2F regulation. Mol. Cell Biol. 2000 20 : 4745 4753.
34. Kim J, Kim SH, Jhonson VJ et al. Extracellular signal-regulated kinase-signalingdependent G2/M arrest and cell death in murine macrophages by cadmium. Environ. Toxicol. Chem. 2005 3069 3077.
35. Mitchell C, Robin MA, Mayeuf A et al. Protection against Hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. Am. J. Pathol. 2009 175 : 1929 1937.
36. Meredith MJ, Cusick CL, Soltaninassab S, Sekhar KS, Lu S, Freeman ML. Expression of Bcl-2 increases intracellular glutathione by inhibiting methion independent GSH efflux. Biochem. Biophys. Res. Commun. 1998 248 : 458 463.
37. Lee MH, Hyun DH, Marshall KA et al. Effect of overexpression of Bcl-2 on cellular oxidative damage, nitric oxide production, antioxidant defenses and the proteasome. Free Radic. Biol. Med. 2001 31 : 1550 1559.
38. De Vivo G, Martin A, Trotta T, Gentile V. Role of transglutaminase- catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders. Inflamm. Allergy Drug Targets 2008 7 : 24 9.
39. Dalton TP, Shertzer HG, Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 1999 39 : 67 101.
40. García-Ruiz C, Fernández-Checa JC. Redox regulation of hepatocyte apoptosis. J. Gastroenterol. Hepataol. 2007 22 : S38 42.
41. Seyfried J, Evert BO, Schwarz CS et al. Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status. Free Radic. Biol. Med. 2003 34 : 1517 1530.
42. Osman HG, Gabr OM, Lotfy S, Gabr S. Serum levels of Bcl-2 and cellular oxidative stress in patients with viral hepatitis. Ind. J. Med. Microbiol. 2007 25 : 323 329.
43. Piekarska A, Kubiak R, Omulecka A, Szymczak W. Piekarski Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C. J. Histopathol. 2007 50 : 928 935. (Pubitemid 46850071)